BioCardia (BCDA) to Release Earnings on Wednesday

BioCardia (NASDAQ:BCDA) will be issuing its quarterly earnings data after the market closes on Wednesday, November 13th. Analysts expect BioCardia to post earnings of ($1.19) per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

BioCardia (NASDAQ:BCDA) last issued its quarterly earnings results on Tuesday, August 13th. The company reported ($0.88) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.78). On average, analysts expect BioCardia to post $-5 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

BioCardia Price Performance

Shares of NASDAQ BCDA opened at $2.26 on Monday. BioCardia has a fifty-two week low of $1.96 and a fifty-two week high of $23.25. The stock has a market capitalization of $4.80 million, a price-to-earnings ratio of -0.42 and a beta of 1.28. The business has a 50-day moving average of $2.63 and a 200-day moving average of $3.42.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and set a $25.00 price target on shares of BioCardia in a research report on Monday, October 28th.

About BioCardia

BioCardia, Inc, a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. Its lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia.